APA (7th ed.) Citation

SM, C., K, L., A, B., D, K., J, K., K, G., . . . A, C. (2026). BDNF rs6265 polymorphism is not associated with the occurrence of overactive bladder and its response to intradetrusor injection of botulinum neurotoxin type A in female patients. Scientific reports. https://doi.org/10.1038/s41598-026-58792-5

Chicago Style (17th ed.) Citation

SM, Ciećwież, Lewandowska K, Boroń A, Kotlęga D, Kociszewski J, Grocholewicz K, Clark JS, and Ciechanowicz A. "BDNF Rs6265 Polymorphism Is Not Associated with the Occurrence of Overactive Bladder and Its Response to Intradetrusor Injection of Botulinum Neurotoxin Type A in Female Patients." Scientific Reports 2026. https://doi.org/10.1038/s41598-026-58792-5.

MLA (9th ed.) Citation

SM, Ciećwież, et al. "BDNF Rs6265 Polymorphism Is Not Associated with the Occurrence of Overactive Bladder and Its Response to Intradetrusor Injection of Botulinum Neurotoxin Type A in Female Patients." Scientific Reports, 2026, https://doi.org/10.1038/s41598-026-58792-5.